Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Change in Acquisitions & Divestments (2016 - 2020)

Historic Change in Acquisitions & Divestments for Cumberland Pharmaceuticals (CPIX) over the last 9 years, with Q4 2020 value amounting to -$460888.0.

  • Cumberland Pharmaceuticals' Change in Acquisitions & Divestments fell 11053.27% to -$460888.0 in Q4 2020 from the same period last year, while for Sep 2020 it was $4.8 million, marking a year-over-year decrease of 6916.62%. This contributed to the annual value of $20.1 million for FY2019, which is 2443.66% up from last year.
  • Per Cumberland Pharmaceuticals' latest filing, its Change in Acquisitions & Divestments stood at -$460888.0 for Q4 2020, which was down 11053.27% from $460888.0 recorded in Q3 2020.
  • Cumberland Pharmaceuticals' Change in Acquisitions & Divestments' 5-year high stood at $9.2 million during Q3 2018, with a 5-year trough of -$460888.0 in Q4 2020.
  • Moreover, its 5-year median value for Change in Acquisitions & Divestments was $2.1 million (2016), whereas its average is $3.2 million.
  • Its Change in Acquisitions & Divestments has fluctuated over the past 5 years, first skyrocketed by 97273.43% in 2017, then crashed by 11053.27% in 2020.
  • Quarter analysis of 5 years shows Cumberland Pharmaceuticals' Change in Acquisitions & Divestments stood at $812366.0 in 2016, then soared by 359.95% to $3.7 million in 2017, then soared by 146.71% to $9.2 million in 2018, then plummeted by 52.53% to $4.4 million in 2019, then plummeted by 110.53% to -$460888.0 in 2020.
  • Its last three reported values are -$460888.0 in Q4 2020, $460888.0 for Q3 2020, and $4.4 million during Q4 2019.